Network-based machine learning in colorectal and bladder organoid models predicts anti-cancer drug efficacy in patients
J. Kong, H. Lee, et al.
Explore these studies to deepen your understanding
Adjacent work that informs or extends this paper's methodology and findings.
Drug ranking using machine learning systematically predicts the efficacy of anti-cancer drugs
H. Gerdes, P. Casado, et al.
Therapeutic efficacy of a MMAE-based anti-DR5 drug conjugate Oba01 in preclinical models of pancreatic cancer
C. Zheng, D. Zhou, et al.
Efficacy of early PET-CT directed switch to carboplatin and paclitaxel based definitive chemoradiotherapy in patients with oesophageal cancer who have a poor early response to induction cisplatin and capecitabine in the UK: a multi-centre randomised controlled phase II trial
S. Mukherjee, C. N. Hurt, et al.
A machine learning-based chemoproteomic approach to identify drug targets and binding sites in complex proteomes
I. Piazza, N. Beaton, et al.
